18 April 201712 April 2017 Hitachi is selected by Sumitomo Dainippon Pharma for Automated Cell Mass Culture Equipment for Regenerative Medicine using Human iPS Cells Research equipment for the manufacturing cells used in Parkinson's disease treatment
